Core Scientific vs IREN
CORZ and IREN side by side, both in finance services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CORZ and IREN compare
IREN grew revenue faster over the last twelve months (41.1% versus 26.4% for Core Scientific).
IREN keeps more of each dollar of sales as profit, with a net margin of −99.4% compared with −325% at Core Scientific.
IREN scores higher on the StockData Score (6 against 2 for Core Scientific), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CORZ | IREN |
|---|---|---|
| Size and price | ||
| Market cap | $4.4B | – |
| Share price | $13.58 | $16.39 |
| Change, 1 year | −10.4% | −66.3% |
| Change, 5 years | – | −13.7% |
| Beta (5Y) | 2.43 | 3.29 |
| Employees | 325 | 685 |
| StockData Score | ||
| Total score | 2 | 6 (better) |
| Valuation score | 0 | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 0 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 9.9× | – |
| FCF yield | −21.9% | – |
| Fair value | $3.49 | – |
| Margin of safety | −289% | – |
| Growth | ||
| Revenue growth (TTM) | 26.4% | 41.1% (better) |
| Revenue growth, 5Y average | 39.5% | 146% (better) |
| Net income growth (TTM) | – | −908% |
| Profitability | ||
| Gross margin | 28.3% | 68.9% (better) |
| Operating margin | −127% (better) | −148% |
| Net margin | −325% | −99.4% (better) |
| FCF margin | −218% | −127% (better) |
| Return on equity | – | −23.4% |
| Return on invested capital | – | −20.4% |
| Financial health | ||
| Debt / equity | – | 1.81 |
| Interest coverage | – | −17.7× |
| Current ratio | 0.89 | 3.55 (better) |
| Altman Z-score | −1.50 | – |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Years of dividend growth | – | 0 |
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 136% | 54.5% |
| Held by insiders | 11.7% | 7.9% |
| Insider net buying, 12 months | −$6.2M | – |
| Superinvestors holding | 3 (better) | 1 |
| Short interest, % of float | – | 26.1% |
Go deeper
- CORZ stock overview
- CORZ income statement
- CORZ valuation and score
- IREN stock overview
- IREN income statement
- IREN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.